Salutas Pharma GmbH v Hauptzollamt Hanover

European Union – Customs and excise. The Court of Justice of the European Union gave a preliminary ruling, deciding that the Combined Nomenclature in Annex I to Council Regulation (EEC) No 2658/87, as amended, should be interpreted as meaning that a product, such as effervescent tablets with a calcium content of 500 mg per tablet that was used for the prevention and treatment of a calcium deficiency and to support a special therapy for the prevention and treatment of osteoporosis, and for which the maximum recommended daily dose for adults indicated on the label was 1,500 mg, fell within heading 3004 of that nomenclature.

Category: